A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
76
Participants
Timeline
Start Date
November 30, 2001
Study Completion Date
November 30, 2005
Conditions
Stage IIB Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IV Breast CancerBreast CancerLocally Advanced
Interventions
DRUG
gemcitabine, epirubicin, paclitaxel
Trial Locations (1)
15212
NSABP Foundation, Inc., Pittsburgh
All Listed Sponsors
lead
NSABP Foundation Inc
NETWORK
NCT00378313 - A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer | Biotech Hunter | Biotech Hunter